BioSpace News Archive

3 Biotechs That Got Huge Boosts From Spark's FDA P

BioCapital

4 Biotechs Facing Do-or-Die Catalysts in December

As 2018 winds down, it’s not over for some biopharma companies.

December 6, 2017

·

3 min read

·

Mark Terry

Arthrex to Create 1,000 Jobs With New $74M Facilit

UK Science Gets More Post-Brexit Love From GlaxoSmithKline, Other Drugmakers

The move is welcome news for Prime Minister Theresa May, who has struggled to win over large sections of industry as Britain prepares to leave the European Union.

December 6, 2017

·

1 min read

Titan Medical Seals Upsized $18M Funding Round

The funding round brought in nearly $4 million more than it was originally expecting.

December 6, 2017

·

1 min read

Policy

Medtronic Partner Mazor Robotics’ CEO Under Investigation for Insider Trading

The investigation dates back to a probe launched in May by Israel’s version of the U.S. SEC though the subject matter of the investigation was not initially revealed.

December 6, 2017

·

1 min read

Drug Development

ASIT Biotech Significantly Moves Forward in the Preparation of the Clinical Development Plan of gp-ASIT+ in the U.S.

ASIT biotech has received positive feedback from the FDA on the preparation of the clinical development plan for gp-ASIT+ in the U.S., with only a few comments and the request for some clarification on the Master File.

December 6, 2017

·

5 min read

Business

What You Need to Know About Fibrocor Therapeutics

Based in Toronto, Ontario, Fibrocor Therapeutics was launched in January 2017.

December 6, 2017

·

5 min read

·

Mark Terry

Ignyta Stock Booms on Promising Mid-Stage Lung Can

Policy

SoCal’s Avanir Scrutinized for Nudexta Prescriber Support Program

Avanir is under fire after CNN filed a report showing how the company paid 500 prescribers about $14M over three years for prescribers to tout the benefits of its leading CNS drug Nuedexta.

December 6, 2017

·

2 min read

·

Alex Keown